Calenfa en es it fr

Calenfa Brand names, Calenfa Analogs

Calenfa Brand Names Mixture

  • No information avaliable

Calenfa Chemical_Formula


Calenfa RX_link

Calenfa fda sheet

Calenfa msds (material safety sheet)

Calenfa Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Calenfa Molecular Weight

260.33 g/mol

Calenfa Melting Point

92-93 oC

Calenfa H2O Solubility

0.3 mg/ml

Calenfa State


Calenfa LogP


Calenfa Dosage Forms


Calenfa Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Calenfa Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Calenfa Absorption

No information avaliable

Calenfa side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Calenfa Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Calenfa Organisms Affected

Humans and other mammals